Qihui Wang
wangqihui@im.ac.cn
Chinese, English
Beijing
University of Chinese Academy of Sciences
Medical School
  • 2006-09--2012-01 Ph.D.: Institute of Biophysics, Chinese Academy of Sciences
  • 2002-09--2006-07 Bachelor's Degree: Harbin Institute of Technology
  • Published over 100 research papers in journals like Cell, Nature, Immunity, Science Translational Medicine
  • Selected as a Highly Cited Researcher by Clarivate Analytics in 2022
  • Selected as a Highly Cited Scholar in China by Elsevier in 2023
  • 2020-10~Present - Institute of Microbiology, Chinese Academy of Sciences - Researcher
  • 2015-10~2020-10 - Institute of Microbiology, Chinese Academy of Sciences - Associate Researcher
  • 2014-07~2015-09 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher
  • 2012-02~2014-06 - Institute of Microbiology, Chinese Academy of Sciences - Postdoctoral Researcher
  • Elsevier Highly Cited Scholar in China (2023): 2024
  • Beijing Advanced Science and Technology Worker: 2023
  • 10th Shulan Medical Youth Award: 2023
  • Clarivate Analytics Highly Cited Researcher: 2022
  • Outstanding Member of the Youth Innovation Promotion Association of the Chinese Academy of Sciences: 2022
  • First Chinese Academy of Sciences Youth May Fourth Medal: 2022
  • Top Ten Advances in Chinese Life Sciences: 2022
  • Advanced Individual in the National Science and Technology System for Fighting COVID-19: 2021
  • Chinese Academy of Sciences Youth Scientist Award: 2021
  • Beijing Chaoyang District 2021 Phoenix Plan Youth Top Talent: 2021
  • 14th Wu Mengchao Medical Youth Fund Award: 2021
  • 14th Tan Jiazhen Life Science Innovation Award: 2021
  • National March 8th Red Flag Collective Award for Fighting COVID-19: 2020
  • Zhongyuan Concord Life Medicine Innovation Breakthrough Award: 2017
Virus infection mechanisms and immune intervention methods
Development of mRNA vaccines for infectious diseases
Design and development of new antiviral drugs
Research and design of long-acting vaccines
  • A broadly neutralizing nanobody targeting the highly conserved S2 subunit of sarbecoviruses, Xiaoyun Wang, Yufeng Xie, Honghui Liu, Wenwen Lei, Ke Xu, Lili Wu, Ruiwen Fan, Guizhen Wu, George Fu Gao, Qihui Wang, 2023
  • Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine, Qian Chen, Pei Du, Yuxuan Han, Xuehui Ma, Rong Zhang, Xiaoyu Rong, Xu Zhao, Renyi Ma, Huiting Yang, Anqi Zheng, Qingrui Huang, Jinghua Yan, Hui Wang, Xin Zhao, Lianpan Dai, George F Gao, Qihui Wang, 2023
  • Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice, Honghui Liu, Lili Wu, Bo Liu, Ke Xu, Wenwen Lei, Jianguo Deng, Xiaoyu Rong, Pei Du, Lebing Wang, Dongbin Wang, Xiaolong Zhang, Chao Su, Yuhai Bi, Hua Chen, William J Liu, Jianxun Qi, Qingwei Cui, Shuhui Qi, Ruiwen Fan, Jingkun Jiang, Guizhen Wu, George F Gao, Qihui Wang, 2023
  • An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB, He, Qingwen, Wu, Lili, Xu, Zepeng, Wang, Xiaoyun, Xie, Yufeng, Chai, Yan, Zheng, Anqi, Zhou, Jianjie, Qiao, Shitong, Huang, Min, Shang, Guijun, Zhao, Xin, Feng, Youjun, Qi, Jianxun, Gao, George Fu, Wang, Qihui, 2023
  • A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery, Wu, Lili, Zheng, Anqi, Tang, Yangming, Chai, Yan, Chen, Jiantao, Cheng, Lin, Hu, Yu, Qu, Jing, Lei, Wenwen, Liu, William Jun, Wu, Guizhen, Zeng, Shaogui, Yang, Hang, Wang, Qihui, Gao, George Fu, 2023
  • Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs, Hu, Yu, Liu, Kefang, Han, Pu, Xu, Zepeng, Zheng, Anqi, Pan, Xiaoqian, Jia, Yunfei, Su, Chao, Tang, Lingfeng, Wu, Lili, Bai, Bin, Zhao, Xin, Tian, Di, Chen, Zhihai, Qi, Jianxun, Wang, Qihui, Gao, George F, 2023
  • mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2, Han, Yuxuan, An, Yaling, Chen, Qian, Xu, Kun, Liu, Xueyuan, Xu, Senyu, Duan, Huixin, Vogel, Annette B, Sahin, Ugur, Wang, Qihui, Dai, Lianpan, Gao, George F, 2022
  • Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants, Su, Chao, He, Juanhua, Han, Pengcheng, Bai, Bin, Li, Dedong, Cao, Jian, Tian, Mingxiong, Hu, Yu, Zheng, Anqi, Niu, Sheng, Chen, Qian, Rong, Xiaoyu, Zhang, Yanfang, Li, Weiwei, Qi, Jianxun, Zhao, Xin, Yang, Mengsu, Wang, Qihui, Gao, George Fu, 2022
  • Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017, Jia, Yunfei, Niu, Sheng, Hu, Yu, Chai, Yan, Zheng, Anqi, Su, Chao, Wu, Lili, Han, Pengcheng, Han, Pu, Lu, Dan, Liu, Zhimin, Yan, Xinxi, Tian, Di, Chen, Zhihai, Qi, Jianxu, Tian, Wenxia, Wang, Qihui, Gao, George Fu, 2022
  • Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3, Huang, Min, Wu, Lili, Zheng, Anqi, Xie, Yufeng, He, Qingwen, Rong, Xiaoyu, Han, Pu, Du, Pei, Han, Pengcheng, Zhang, Zengyuan, Zhao, Runchu, Jia, Yunfei, Li, Linjie, Bai, Bin, Hu, Ziliang, Hu, Shixiong, Niu, Sheng, Hu, Yu, Liu, Honghui, Liu, Bo, Cui, Kaige, Li, Weiwei, Zhao, Xin, Liu, Kefang, Qi, Jianxun, Wang, Qihui, Gao, George Fu, 2022
  • Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals, Li, Shihua, Yang, Ruirui, Zhang, Di, Han, Pu, Xu, Zepeng, Chen, Qian, Zhao, Runchu, Zhao, Xin, Qu, Xiao, Zheng, Anqi, Wang, Liang, Li, Linjie, Hu, Yu, Zhang, Rong, Su, Chao, Niu, Sheng, Zhang, Yanfang, Qi, Jianxun, Liu, Kefang, Wang, Qihui, Gao, George F, 2022
  • Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses, Xu, Zepeng, Kang, Xinrui, Han, Pu, Du, Pei, Li, Linjie, Zheng, Anqi, Deng, Chuxia, Qi, Jianxun, Zhao, Xin, Wang, Qihui, Liu, Kefang, Gao, George Fu, 2022
  • The mysterious origins of the Omicron variant of SARS-CoV-2, Pei Du, George Fu Gao, Qihui Wang, 2022
  • Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape, Zhennan Zhao, Jingya Zhou, Mingxiong Tian, Min Huang, Sheng Liu, Yufeng Xie, Pu Han, Chongzhi Bai, Pengcheng Han, Anqi Zheng, Lutang Fu, Yuanzhu Gao, Qi Peng, Ying Li, Yan Chai, Zengyuan Zhang, Xin Zhao, Hao Song, Jianxun Qi, Qihui Wang, Peiyi Wang, George F Gao, 2022
  • Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin (vol 40, e107786, 2021), Niu, Sheng, Wang, Jia, Bai, Bin, Wu, Lili, Zheng, Anqi, Chen, Qian, Du, Pei, Han, Pengcheng, Zhang, Yanfang, Jia, Yunfei, Qiao, Chengpeng, Qi, Jianxun, Tian, Wenxia, Wang,
Virus Infection Immune Intervention Mrna Vaccine Antiviral Drug Long-Acting Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.